Chimeron Bio Alternatives & Competitors

12 companies similar to Chimeron Bio — Redefining genetic medicine with future-forward RNA technology designed to deliv...

Function

Personalized functional genomics transforming the future of cancer

7 Series A $28.00M

San Diego, United States

Biotechnology Health and Wellness

AAVantgarde Bio

Delivering the next generation gene therapies

19 Series A $61.00M

Milano, Italy

Biotechnology Health Care

Fore Biotherapeutics

A precision oncology company rooted in science and innovation, developing cancer therapies...

46 Series D $166.50M

Philadelphia, United Stat...

Biotechnology Health Care

PMV Pharmaceuticals, Inc.

Harnessing the power of p53 to treat cancer

70 Series D $236.00M

Princeton, United States

Biopharma Biotechnology +2

Rival Readout

Competing with Chimeron Bio? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Phlox Therapeutics

RNA's to rescue cardiomyopathies

Naarden, The Netherlands

Biotechnology Health and Wellness

Korro Bio, Inc.

Edit the message. Rewrite the future. Pioneering RNA editing to deliver the future of medi...

75 IPO $479.50M

Cambridge, United States

Biotechnology Health Care +1

Nancy J Kelley + Associates

We build things that matter for science and medicine.

New York, United States

Biotechnology Financial Services +1

Vineti

Vineti’s Personalized Therapy Management (PTM®) drives and scales advanced therapies

20 Series C $115.30M

San Francisco, United Sta...

Biotechnology Computing +2

Carbon Biosciences

Expanding Therapeutic Potential with Novel Parvovirus Gene Therapy

12 Series A $38.00M

Boston, United States

Biotechnology Health and Wellness

MiraDx

Tailoring cancer treatment based on your patient’s unique response and toxicity profile.

28 Series A $4.00M

Los Angeles, United State...

Biotechnology Health Care

TransCode Therapeutics, Inc.

Delivering a cancer-free future

11 Post-IPO Equity $28.05M

Newton, United States

Biotechnology Health Care +1

Laronde

Pioneering a completely novel translatable RNA platform - Endless RNA (eRNA)

44 Series B $490.00M

Cambridge, United States

Biotechnology Health and Wellness

About Chimeron Bio

Chimeron Bio is a biotech company founded in 2015 with a focus on developing personalized gene therapies, starting with cancer. The company's slogan "Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy" reflects their commitment to leveraging cutting-edge technology in the...

Business keywords

Biotech, Synthetic Genomics, RNA Therapy, Personalized Gene Therapies, Cancer Treatment, Genetic Engineering, Biomedical Technology, Precision Medicine, Pharmaceuticals, Innovation, Biomedical Research, Startup, Investment, Science

Frequently Asked Questions

Companies similar to Chimeron Bio include Function, AAVantgarde Bio, Fore Biotherapeutics, PMV Pharmaceuticals, Inc., Phlox Therapeutics. They work in Biotechnology and Health Care and share Chimeron Bio's focus on precision medicine, innovation and biomedical research.

Bounce Watch lists 12 companies that share Chimeron Bio's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Chimeron Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Chimeron Bio Profile Function Alternatives AAVantgarde Bio Alternatives Fore Biotherapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Chimeron Bio on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.